By Mill Chart
Last update: Jul 23, 2024
For growth-minded investors, high revenue and EPS growth are key criteria. Today, we'll examine whether DOXIMITY INC-CLASS A (NYSE:DOCS) fits the bill for growth investing, particularly as it forms a base and hints at a potential breakout. Remember, due diligence is essential, but DOXIMITY INC-CLASS A has caught our attention on our screen for growth with base formation. It may warrant additional investigation.
ChartMill employs its own Growth Rating system for all stocks. This score, ranging from 0 to 10, is derived by evaluating different growth factors, such as EPS and revenue growth, taking into account both past performance and future projections. NYSE:DOCS has earned a 8 for growth:
A critical element of ChartMill's stock evaluation is the Health Rating, which spans from 0 to 10. This rating considers multiple health factors, including liquidity and solvency, both in absolute terms and relative to industry peers. NYSE:DOCS has received a 9 out of 10:
ChartMill utilizes a Profitability Rating to assess stocks, scoring them on a scale of 0 to 10. This rating takes into account a variety of profitability ratios and margins, both in absolute terms and in comparison to industry peers. NYSE:DOCS has earned a 9 out of 10:
Besides the Technical Rating, ChartMill also assign a Setup Rating to every stock. This setup score also ranges from 0 to 10 and determines to which extend the stock is consolidating. This is achieved by evaluating multiple short term technical indicators. NYSE:DOCS currently has a 8 as setup rating:
Although the technical rating is only medium, DOCS does present a nice setup opportunity. Prices have been consolidating lately. There is a resistance zone just above the current price starting at 29.38. Right above this resistance zone may be a good entry point. There is a support zone below the current price at 28.00, a Stop Loss order could be placed below this zone.
Our Strong Growth screener lists more Strong Growth stocks and is updated daily.
Check the latest full fundamental report of DOCS for a complete fundamental analysis.
Check the latest full technical report of DOCS for a complete technical analysis.
This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.
53.21
+0.43 (+0.81%)
Find more stocks in the Stock Screener
NYSE:DOCS is scoring great on several growth aspects while it also shows decent health and profitability. At the same time it remains remains attractively priced.